Early Indicator Stock on the Move for Thursday, February 22, 2007: New Licensing Agreement!

Market Wire, February, 2007

TheSUBWAY.com names the following stocks to its Stock Alert List: Stem Cell Innovations, Inc. (OTCBB: SCLL), Linear Technology Corporation (NASDAQ: LLTC), Amgen (NASDAQ: AMGN), Gmarket Inc. (NASDAQ: GMKT).

Stem Cell Innovations, Inc. (OTCBB: SCLL) (Stem Cell) just announced a licensing agreement and stock swap with Pluristem Life Systems, Inc. (Pluristem) for certain marketing rights of Pluristem's PLX I product in Asia, excluding Japan and 3-D stem cell expansion capability. The licensing agreement provides Stem Cell with certain rights to Pluristem's PLX I product and 3-D stem cell expansion capability, in exchange for an upfront fee of 23 million shares of Stem Cell's common stock, milestone payments and royalties.

Stem Cell CEO Dr. James Kelly commented, "We are excited with Pluristem's 3-D stem cells expansion capability for use in conjunction with our PluriCell technology. We believe this collaboration will improve our product development capabilities, leading to better solutions for both in vivo and in vitro applications and improve our shareholder value." SCI is a cell biology company with facilities in Scotch Plains, NJ, Houston, TX and in Leiden, the Netherlands. Stem Cell Innovations proprietary, human pluripotent stem cells, known as PluriCells, have the potential to aid in drug discovery, toxicology, and cell therapy.

Other stocks highlighted include Linear Technology Corporation (NASDAQ: LLTC): Stock Pick List, up 1% on 4 million shares, Amgen (NASDAQ: AMGN): Stock Pick List, up 2% on 16 million shares, Gmarket Inc. (NASDAQ: GMKT): Stock Pick List, down 1% on 1 million shares.

"The real estate market continues to be the wild card in the broader economy, and even has stock market investors worried as well. Indeed, some markets saw price appreciation rates of as much as 50%, while the national average was better than 10%. But as home price trends tend to lag behind sales trends by about nine to 12 months, many are predicting home prices will be weakest in 2008 and perhaps even into 2009." More is available at: http://www.thesubway.com .

TheSUBWAY.com's Daily Stock Updates:

TheSUBWAY.com, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a "long term" view of any of the companies listed. For more go to http://www.thesubway.com .

All material herein was prepared by Capital Research Group, Inc. (CRG) based upon information believed to be reliable. The information contained herein is not guaranteed by CRG to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.thesubway.com or mentioned herein. CRG has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion. CRG has been compensated fifty thousand dollars for SCLL. CRG may receive up to one hundred thousand dollars for SCLL. CRG intends to sell its shares. CRG has sold approximately zero SCLL shares to date. CRG may sell its shares for less than the target price given in this opinion. In addition to any compensation mentioned above, additional compensation can be equal to ten percent of any newly issued or registered securities of the profiled companies. CRG's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. CRG will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

CONTACT: Capital Research Group Charles Tamburello 954-217-8555 www.TheSUBWAY.com